Updated: Feb 17, 2009
Stridor is a clinical sign characterized by monophonic, audible breath sounds (noisy breathing) that usually originates from the extrathoracic airways. The presence of stridor indicates a partial obstruction of the upper airways, glottis, or trachea. The pitch of the stridor is determined by the degree of airway obstruction and the velocity of the airflow; the loudness and tone of the sound also varies by the specific cause. Congenital stridor presents at birth or within the first few weeks (4-6) of life.1
Stridor results from partial obstruction of an airway with turbulent flow characteristics. Such respiratory tract areas are the upper airway, glottis, and trachea. The obstruction can be fixed or variable. Variable extrathoracic obstructions are primarily associated with inspiratory stridor. This is because, during inspiration, extrathoracic intraluminal airway pressure is negative relative to atmospheric pressure, leading to collapse of supraglottic structures. During expiration, intrathoracic pressure is positive and tends to collapse the airway. Thus, stridor caused by intrathoracic obstructions tends to be more prominent upon expiration. Stridor heard during both phases of respiration is usually due to either a fixed airway obstruction or to 2 areas of obstruction (ie, intrathoracic and extrathoracic).
Congenital stridor is rarely life-threatening. Immediately life-threatening obstruction from congenital lesions such as severe micrognathia are apparent at birth, and are treated with emergent tracheotomy. Bilateral vocal cord paralysis and subglottic hemangioma may present as causes of congenital stridor that are life-threatening. Significant airway obstruction can lead to respiratory distress and failure to thrive, secondary to the increased work of breathing.
Congenital stridor is present either at birth or shortly afterward.
The most common presentation for congenital stridor is chronic noisy breathing since birth. Most patients come to attention by the first 4-6 weeks of life. The stridor may emerge only after a few weeks, as the baby gains strength and airflow velocity increases during that time.
The history can be helpful in determining the cause of stridor. Characteristics of stridor that should be elicited include the following:
Physical examination should focus on examination of the respiratory tract, the quality and characteristics of the stridor, and other physical findings that may be associated with stridor.
Differential diagnosis of stridor can be divided into supralaryngeal, laryngeal, tracheal, and nonanatomic categories.
| Laryngomalacia | Vascular Ring, Double Aortic Arch |
| Pulmonary Artery Sling | Vascular Ring, Right Aortic Arch |
| Stridor | |
| Subglottic Stenosis | |
| Tracheomalacia |
Gastroesophageal reflux (GER)
Foreign body aspiration
Laryngeal stenosis
Medical care is primarily supportive because many causes of congenital stridor resolve spontaneously over time. For those that do not, such as vascular rings, surgical treatment is usually definitive. However, in some patients, tracheomalacia persists for some time after such a repair. In severe cases of congenital stridor, nonsurgical therapy may have a role prior to definitive surgical correction.
Surgical management depends on the specific lesion that causes stridor.
The major medical pitfall in evaluation of congenital stridor is failure to make the diagnosis.
Belmont JR, Grundfast K. Congenital laryngeal stridor (laryngomalacia): etiologic factors and associated disorders. Ann Otol Rhinol Laryngol. Sep-Oct 1984;93(5 Pt 1):430-7. [Medline].
Berdon WE, Baker DH. Vascular anomalies and the infant lung: rings, slings, and other things. Semin Roentgenol. Jan 1972;7(1):39-64. [Medline].
Zalzal GH, Anon JB, Cotton RT. Epiglottoplasty for the treatment of laryngomalacia. Ann Otol Rhinol Laryngol. Jan-Feb 1987;96(1 Pt 1):72-6. [Medline].
Cotton RT. Pediatric laryngotracheal stenosis. J Pediatr Surg. Dec 1984;19(6):699-704. [Medline].
Cotton RT, Evans JN. Laryngotracheal reconstruction in children. Five-year follow-up. Ann Otol Rhinol Laryngol. Sep-Oct 1981;90(5 Pt 1):516-20. [Medline].
Cotton RT, Schreiber JT. Management of laryngotracheoesophageal cleft. Ann Otol Rhinol Laryngol. Jul-Aug 1981;90(4 Pt 1):401-5. [Medline].
McSwiney PF, Cavanagh NP, Languth P. Outcome in congenital stridor (laryngomalacia). Arch Dis Child. Mar 1977;52(3):215-8. [Medline].
Nielson DW, Heldt GP, Tooley WH. Stridor and gastroesophageal reflux in infants. Pediatrics. Jun 1990;85(6):1034-9. [Medline].
Orenstein SR, Kocoshis SA, Orenstein DM, Proujansky R. Stridor and gastroesophageal reflux: diagnostic use of intraluminal esophageal acid perfusion (Bernstein test). Pediatr Pulmonol. Nov-Dec 1987;3(6):420-4. [Medline].
Parnell FW, Brandenburg JH. Vocal cord paralysis. A review of 100 cases. Laryngoscope. Jul 1970;80(7):1036-45. [Medline].
Richardson MA, Cotton RT. Anatomic abnormalities of the pediatric airway. Ear Nose Throat J. Jan 1985;64(1):47-60. [Medline].
Stanger P, Lucas RV Jr, Edwards JE. Anatomic factors causing respiratory distress in acyanotic congenital cardiac disease. Special reference to bronchial obstruction. Pediatrics. May 1969;43(5):760-9. [Medline].
Weiss LN. The diagnosis of wheezing in children. Am Fam Physician. Apr 15 2008;77(8):1109-14. [Medline].
congenital stridor, congenital croup, chronic congestion, obstruction of airway, noisy breathing, obstruction of trachea, trachea obstruction, micrognathia, bilateral vocal cord paralysis, subglottic hemangioma, airway obstruction, respiratory distress, failure to thrive, increased work of breathing, laryngomalacia, Arnold-Chiari malformation, webs, cysts, papillomata, and laryngotracheoesophageal clefts, subglottic stenosis, double aortic arch, pulmonary artery sling, bronchogenic cyst, tracheomalacia, gastroesophageal reflux, GER, cardio-vocal syndrome, airway foreign body
Timothy D Murphy, MD, Assistant Professor, Department of Pediatrics, Division of Pulmonology, University of Pittsburgh; Consulting Staff, Division of Pulmonology, Children's Hospital of Pittsburgh
Disclosure: Nothing to disclose.
Clement L Ren, MD,, Chief, Division of Pediatric Pulmonology, Department of Pediatrics, Associate Professor, Golisano Children's Hospital at Strong, University of Rochester, New York
Clement L Ren, MD, is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American College of Chest Physicians, and American Thoracic Society
Disclosure: Nothing to disclose.
Thomas Scanlin, MD, Chief, Division of Pediatric Pulmonary & Cystic Fibrosis, Assistant Professor, Department of Pediatrics, Robert Wood Johnson University Medical Group
Thomas Scanlin, MD is a member of the following medical societies: American Thoracic Society and Society for Pediatric Research
Disclosure: Nothing to disclose.
Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner
Charles Callahan, DO, Professor, Deputy Chief of Clinical Services, Walter Reed Army Medical Center
Charles Callahan, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American College of Osteopathic Pediatricians, American Thoracic Society, Association of Military Surgeons of the US, and Christian Medical & Dental Society
Disclosure: Nothing to disclose.
Mary E Cataletto, MD, Associate Director, Division of Pediatric Pulmonology, Winthrop University Hospital; Professor of Clinical Pediatrics, State University of New York at Stony Brook; Director of Children's Sleep Services, Winthrop University Hospital
Mary E Cataletto, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Chest Physicians
Disclosure: Shering Plough Pharmaceuticals Honoraria Consulting
Michael R Bye, MD, Professor of Clinical Pediatrics, Division of Pulmonary Medicine, Columbia University College of Physicians and Surgeons; Attending Physician, Pediatric Pulmonary Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center
Michael R Bye, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, and American Thoracic Society
Disclosure: Merck Honoraria Speaking and teaching
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)